[company_age]18.0[/company_age][employees]2-10 employees[/employees][description]TYDOCK PHARMA is a biotechnology company established in 2006, specializing in drug discovery and early development, particularly for parasitic diseases like tuberculosis, malaria, and protozoan infections.  They have a strong track record of collaboration with universities and other biotech companies, and have received research grants from the European Commission.  Their expertise is built on 20 years of experience, and they were recognized in 2009 as one of Italy's most promising and innovative biotechnology companies.  In addition to drug discovery, TYDOCK PHARMA also engages in technology transfer projects, bridging the gap between basic research and industrial applications.[/description][ps]Chemotherapeutic drugs for parasitic diseases, analytical services, custom synthesis, unique compound libraries.[/ps]